Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil plus modafinil and paracetamol in mild to moderate Alzheimer's disease
ChiCTR2000035256Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Nanchang University
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of donepezil, modafinil and acetaminophen in Alzheimer's disease (AD) (2 arms), sponsored by The Second Affiliated Hospital of Nanchang University. Primary endpoint: Change in ADAS-Cog from baseline to week 24. Planned start Nov 2020; status: not yet recruiting.
02
Drugs
donepezilmodafinilacetaminophen
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on ChiCTR2000035256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035256.